Prostate cancer trials in Australia
82 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleLu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
- Where
- Melbourne, St Leonards
- Age
- 18 years and over
- People
- 92 worldwide
- Run by
- Peter MacCallum Cancer Centre, Australia
See details and how to joinNCT05560659 - Phase 1/2Taking peopleFirst-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- Where
- Melbourne
- Age
- 18 years and over
- People
- 54 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07332455 - Phase 2Taking peopleA Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
- Where
- Birtinya, Box Hill, Herston, St Leonards
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07287150 · EU 2025-521327-67-00 - Phase 3Taking peopleStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Where
- Brisbane, Dubbo, Macquarie University, Melbourne, Westmead
- Age
- 18 years and over
- People
- 1,310 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136624 · EU 2023-504899-25-00 - Phase 1/2Taking peopleA Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
- Where
- Darlinghurst, Heidelberg
- Age
- 18 years and over
- People
- 260 worldwide
- Run by
- Genentech, Inc.
See details and how to joinNCT07567846 - Phase 1Taking peopleA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Where
- Darlinghurst, Nedlands
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00 - Phase 1Enrolling by invitationA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Macquarie University, Melbourne, Nedlands, Randwick
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - Phase 1Taking peopleA Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
- Where
- Clayton, Darlinghurst, Heidelberg, New South Wales
- Age
- 18 years and over
- People
- 210 worldwide
- Run by
- Genentech, Inc.
See details and how to joinNCT05800665 · EU 2023-504013-68-00 - Phase 1Taking peopleA Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
- Where
- Adelaide, Macquarie Park, Melbourne, Woolloongabba
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05818683 · EU 2022-503132-14-00 - Phase 1Taking peopleA Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Where
- Greenslopes, Melbourne
- Age
- 18 years and over
- People
- 355 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06095089 · EU 2023-504063-17-00 - Phase 3Taking peopleA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Where
- Heidelberg, Kurralta Park, Melbourne, Murdoch, Woolloongabba
- Age
- 18 years and over
- People
- 1,203 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07164443 · EU 2025-520927-26-00 - Phase 3Taking peopleA Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Where
- Heidelberg, Kurralta Park, Melbourne, Wahroonga, Woolloongabba
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07225946 · EU 2025-522713-29-00 - Phase 2Taking peopleA Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
- Where
- Chermside, East Melbourne, Hobart, Kurralta Park
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07832292 - Phase 3Taking peopleA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Where
- Blacktown, Greenslopes, Macquarie University, Melbourne, Murdock
- Age
- 18 years and over
- People
- 1,440 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06925737 · EU 2024-517423-40-00 - Phase 1/2Taking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Ballarat, Camperdown, Frankston, Saint Leonards, Waratah
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - Phase 1Taking peopleStudy of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Where
- Bedford Park, Camperdown, Nedlands
- Age
- 18 years to 100 years
- People
- 272 worldwide
- Run by
- Janux Therapeutics
See details and how to joinNCT05519449 · EU 2026-526777-42-00 - Phase 2Taking peoplePsilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
- Where
- Abbotsford, Leederville, Melbourne, Northcote
- Age
- 18 years to 80 years
- People
- 87
- Run by
- Psyence Australia Pty Ltd
See details and how to joinNCT07072728 - Phase 1Taking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Auchenflower, Heidelberg, Kurralta Park
- Age
- 18 years and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - Phase 1Taking peopleSafety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Where
- Darlinghurst, Melbourne
- Age
- 18 years and over
- People
- 347 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT05997615 · EU 2023-503495-24-00 - Phase 2Taking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Camperdown, Chermside, Clayton, Hobart, Hyde Park
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - Phase 1Taking peopleA Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Where
- Box Hill, Camperdown, Chermside, Melbourne
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT07244341 · EU 2025-522512-16-00 - Phase 1Taking peopleA Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
- Where
- Melbourne
- Age
- 18 years and over
- People
- 208 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07570979 - Phase 2Taking peopleMultimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy
- Where
- Sydney
- Age
- 18 years and over
- People
- 64
- Run by
- Surgical Outcomes Research Centre (SOuRCe)
See details and how to joinNCT07576335 - Phase 2Taking peopleStudy of PF-07248144 in Advanced or Metastatic Solid Tumors
- Where
- Adelaide, Camperdown, Melbourne, Parkville, St Albans, Subiaco
- Age
- 18 years and over
- People
- 320 worldwide
- Run by
- Pfizer
See details and how to joinNCT04606446 - Phase 1/2Taking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Birtinya, Blacktown, Brisbane, Camperdown, Concord, Gold Coast, Nedlands, New Lambton Heights, Sydney, Waratah
- Age
- 18 years and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116